Scott M. Coiante

Insider Reports History

Entity
Individual
Location
101 Poor Farm Road 3 Rd Floor, Princeton, NJ
Signature
/s/ Scott M. Coiante
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Scott M. Coiante:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Aprea Therapeutics, Inc. SVP, Chief Financial Officer Common Stock 145K $534K $3.68 Jul 28, 2022 Direct
LEXICON PHARMACEUTICALS, INC. SVP, Chief Financial Officer Restricted Stock Units 481K $322K $0.67 Feb 13, 2025 Direct
AGILE THERAPEUTICS INC Chief Financial Officer Common Stock 0 $0 $1.52 Aug 26, 2024 Direct
LEXICON PHARMACEUTICALS, INC. SVP, Chief Financial Officer Stock Option (Right to Buy) 721K Feb 13, 2025 Direct
Aprea Therapeutics, Inc. SVP, Chief Financial Officer Stock Option (right to Buy) 89.2K Jul 28, 2022 Direct

Insider Reports Filed by Scott M. Coiante

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LXRX LEXICON PHARMACEUTICALS, INC. Feb 13, 2025 2 $0 4 Feb 18, 2025 SVP, Chief Financial Officer
LXRX LEXICON PHARMACEUTICALS, INC. Jan 2, 2025 1 $0 4 Jan 2, 2025 SVP, Chief Financial Officer
LXRX LEXICON PHARMACEUTICALS, INC. Jan 2, 2025 0 $0 3 Jan 2, 2025 SVP, Chief Financial Officer
AGRX AGILE THERAPEUTICS INC Aug 26, 2024 2 -$30.5K 4 Aug 26, 2024 Chief Financial Officer
AGRX AGILE THERAPEUTICS INC Oct 3, 2023 1 $0 4 Oct 4, 2023 Chief Financial Officer
AGRX AGILE THERAPEUTICS INC Aug 16, 2023 0 $0 3 Aug 25, 2023 Chief Financial Officer
APRE Aprea Therapeutics, Inc. Jul 28, 2022 2 $0 4 Aug 1, 2022 SVP, Chief Financial Officer
APRE Aprea Therapeutics, Inc. Jun 3, 2022 1 -$28.4K 4 Jun 7, 2022 SVP, Chief Financial Officer, Director
APRE Aprea Therapeutics, Inc. Mar 10, 2022 2 $0 4 Mar 14, 2022 SVP, Chief Financial Officer, Director
APRE Aprea Therapeutics, Inc. Feb 25, 2022 1 -$25.8K 4 Mar 1, 2022 SVP, Chief Financial Officer
APRE Aprea Therapeutics, Inc. Aug 25, 2021 1 -$30K 4 Aug 27, 2021 SVP, Chief Financial Officer